{"id":641823,"date":"2026-10-26T13:46:11","date_gmt":"2026-10-26T13:46:11","guid":{"rendered":"https:\/\/www.newsbeep.com\/nz\/641823\/"},"modified":"2026-10-26T13:46:11","modified_gmt":"2026-10-26T13:46:11","slug":"exploring-the-use-of-glp-1-receptor-agonists-in-breast-cancer-care","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/nz\/641823\/","title":{"rendered":"Exploring The Use of GLP-1 Receptor Agonists in Breast Cancer Care"},"content":{"rendered":"\n<p class=\"\">In a special webinar from CancerNetwork\u00ae, Oncology Nursing News\u00ae, CURE\u00ae, and HCPLive\u00ae, a panel spanning multiple disciplines convened to speak about the use of GLP-1 receptor agonists (GLP-1 RAs) among patients undergoing treatment for breast cancer. The group covered whether GLP-1 RAs were safe for those with breast cancer and described the appropriate circumstances for care teams to consider them.<\/p>\n<p class=\"\">The panel was moderated by Neil M. Iyengar, MD, director of survivorship services at Winship Cancer Institute of Emory University, a clinical member of Winship\u2019s Glenn Family Breast Center, an associate professor and co-director of the Breast Medical Oncology Program in the Department of Hematology and Medical Oncology at Emory University School of Medicine, and co-editor in chief of the journal ONCOLOGY\u00ae. He was joined by:<\/p>\n","protected":false},"excerpt":{"rendered":"In a special webinar from CancerNetwork\u00ae, Oncology Nursing News\u00ae, CURE\u00ae, and HCPLive\u00ae, a panel spanning multiple disciplines convened&hellip;\n","protected":false},"author":2,"featured_media":641824,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[10],"tags":[134,111,139,69],"class_list":["post-641823","post","type-post","status-publish","format-standard","has-post-thumbnail","category-health","tag-health","tag-new-zealand","tag-newzealand","tag-nz"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/posts\/641823","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/comments?post=641823"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/posts\/641823\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/media\/641824"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/media?parent=641823"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/categories?post=641823"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/tags?post=641823"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}